Jeff Hall

Researchers found the use of magnetic resonance spectroscopic imaging revealed pathologic evidence of multiple sclerosis that is not evident on T1 or T2-weighted MRI.

Expanded MRI labeling for Abbott’s Proclaim™ XR Spinal Cord Stimulation System may facilitate increased efficiency and quality of MRI scans.

Will this artificial intelligence technology improve diagnostic accuracy and reduce false positive biopsy orders?

A new meta-analysis examines the diagnostic benefit of this emerging complementary modality.

Emerging research suggests that frontotemporal atrophy on magnetic resonance imaging may be a key finding for chronic traumatic encephalopathy (CTE).

Addition of late contrast enhancement (LCE) CT reportedly bolsters diagnostic rate for patients with acute chest pain who have negative findings on triple-rule-out (TRO) CT.

GE Healthcare unveils on-site detection upgrades and other advances with CT system as well as a new MRI device.